GB2609691A - Patterned bacterial cellulose (BC) composite membrane with biological activity, and preparation method and use thereof - Google Patents
Patterned bacterial cellulose (BC) composite membrane with biological activity, and preparation method and use thereof Download PDFInfo
- Publication number
- GB2609691A GB2609691A GB2204571.0A GB202204571A GB2609691A GB 2609691 A GB2609691 A GB 2609691A GB 202204571 A GB202204571 A GB 202204571A GB 2609691 A GB2609691 A GB 2609691A
- Authority
- GB
- United Kingdom
- Prior art keywords
- patterned
- bacterial cellulose
- preparation
- based membrane
- biological activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 87
- 229920002749 Bacterial cellulose Polymers 0.000 title claims abstract description 68
- 239000005016 bacterial cellulose Substances 0.000 title claims abstract description 68
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- 230000004071 biological effect Effects 0.000 title claims abstract description 25
- 239000002131 composite material Substances 0.000 title abstract description 36
- 239000000463 material Substances 0.000 claims abstract description 21
- 230000000975 bioactive effect Effects 0.000 claims abstract description 13
- 229920005615 natural polymer Polymers 0.000 claims abstract description 13
- 230000037390 scarring Effects 0.000 claims abstract description 9
- 241000894006 Bacteria Species 0.000 claims abstract description 8
- 239000008273 gelatin Substances 0.000 claims abstract description 8
- 229920000159 gelatin Polymers 0.000 claims abstract description 8
- 108010010803 Gelatin Proteins 0.000 claims abstract description 7
- 235000019322 gelatine Nutrition 0.000 claims abstract description 7
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 7
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 5
- 239000001257 hydrogen Substances 0.000 claims abstract description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 21
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 21
- 210000004027 cell Anatomy 0.000 claims description 16
- 229920001436 collagen Polymers 0.000 claims description 14
- 102000008186 Collagen Human genes 0.000 claims description 13
- 108010035532 Collagen Proteins 0.000 claims description 13
- 229920002120 photoresistant polymer Polymers 0.000 claims description 10
- 210000002950 fibroblast Anatomy 0.000 claims description 9
- 206010016654 Fibrosis Diseases 0.000 claims description 8
- 230000004761 fibrosis Effects 0.000 claims description 8
- 230000012010 growth Effects 0.000 claims description 7
- 229920002674 hyaluronan Polymers 0.000 claims description 6
- 229960003160 hyaluronic acid Drugs 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 5
- 238000001459 lithography Methods 0.000 claims description 5
- 230000000295 complement effect Effects 0.000 claims description 4
- 238000009827 uniform distribution Methods 0.000 claims description 4
- 108010013296 Sericins Proteins 0.000 claims description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000001723 curing Methods 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 2
- 238000013007 heat curing Methods 0.000 claims description 2
- 238000007654 immersion Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- -1 polydimethylsiloxane Polymers 0.000 claims description 2
- 229940034586 silk sericin Drugs 0.000 abstract description 24
- 230000017423 tissue regeneration Effects 0.000 abstract description 3
- 238000012258 culturing Methods 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 19
- 208000027418 Wounds and injury Diseases 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000008367 deionised water Substances 0.000 description 13
- 229910021641 deionized water Inorganic materials 0.000 description 13
- 210000003491 skin Anatomy 0.000 description 12
- 230000029663 wound healing Effects 0.000 description 12
- 241000700159 Rattus Species 0.000 description 11
- 230000037380 skin damage Effects 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 238000000349 field-emission scanning electron micrograph Methods 0.000 description 9
- 239000002609 medium Substances 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- NEAPKZHDYMQZCB-UHFFFAOYSA-N N-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]ethyl]-2-oxo-3H-1,3-benzoxazole-6-carboxamide Chemical compound C1CN(CCN1CCNC(=O)C2=CC3=C(C=C2)NC(=O)O3)C4=CN=C(N=C4)NC5CC6=CC=CC=C6C5 NEAPKZHDYMQZCB-UHFFFAOYSA-N 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- 230000008439 repair process Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 241000255789 Bombyx mori Species 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 230000037313 granulation tissue formation Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000012113 quantitative test Methods 0.000 description 4
- 206010063560 Excessive granulation tissue Diseases 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 3
- 229910000397 disodium phosphate Inorganic materials 0.000 description 3
- 235000019800 disodium phosphate Nutrition 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 210000001126 granulation tissue Anatomy 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 238000007634 remodeling Methods 0.000 description 3
- 239000001488 sodium phosphate Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 241000589180 Rhizobium Species 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000012757 fluorescence staining Methods 0.000 description 2
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 2
- 230000002055 immunohistochemical effect Effects 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 238000000879 optical micrograph Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000037314 wound repair Effects 0.000 description 2
- 241000589220 Acetobacter Species 0.000 description 1
- 244000235858 Acetobacter xylinum Species 0.000 description 1
- 235000002837 Acetobacter xylinum Nutrition 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 240000008881 Oenanthe javanica Species 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 108010087230 Sincalide Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000003570 cell viability assay Methods 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000004053 dental implant Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000008560 physiological behavior Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- ABTOQLMXBSRXSM-UHFFFAOYSA-N silicon tetrafluoride Chemical compound F[Si](F)(F)F ABTOQLMXBSRXSM-UHFFFAOYSA-N 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000010388 wound contraction Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
- C08J5/18—Manufacture of films or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0259—Adhesive bandages or dressings characterised by the release liner covering the skin adhering layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
- A61F13/0289—Apparatus or processes for manufacturing adhesive dressings or bandages manufacturing of adhesive dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A61L15/325—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/04—Coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
The preparation method includes the following steps: inverting a template with a patterned structure into a bacteria culture solution capable of synthesizing bacterial cellulose, and culturing for a period of time to obtain a bacterial cellulose-based membrane with a patterned structure (preferably grooved); and immersing the bacterial cellulose-based membrane into a solution of a natural polymer bioactive material (preferably silk sericin or gelatin) such that the bacterial cellulose-based membrane with a patterned structure and the natural polymer bioactive material are compounded through a hydrogen bond to obtain the patterned bacterial cellulose-based membrane with a biological activity. The composite membrane can be used as a wound dressing to rapidly induce skin tissue regeneration or reduce scarring;
Description
PATTERNED BACTERIAL CELLULOSE-BASED COMPOSITE MEMBRANE WITH
BIOLOGICAL ACTIVITY, AND PREPARATION METHOD AND USE THEREOF
TECHNICAL FIELD
[0001] The present disclosure relates to the technical field of biomedical polymer composites, and particularly, to a patterned bacterial cellulose-based composite membrane with biological activity, as well as the preparation method and its application as a wound dressing.
BACKGROUND ART
[0002] Skin damages can expose the body to various harmful substances and even cause serious blood loss. Therefore, to quickly induce the skin to restore a protective function, researchers have designed various wound dressings to restore a physical barrier function of the skin and promote wound healing by accelerating skin tissue regeneration. However, it is a challenge for the wound dressings to restore the integrity of natural tissue structure of the skin. Some of these dressings lack desirable biological activity and cannot accelerate wound healing, while others can induce the wound healing in a relatively short period of time. This may prevent the damaged skin from restoring to an original normal structure.
[0003] During wound treatment, traditional wound dressings such as gauze are easy to adhere to the wound, and have limited clinical use due to the fact that it is easy to damage the wound surface when exchange the wound dressings. Bacterial cellulose (BC) is a natural hydrogel produced and secreted by microorganisms such as Acelobacter, Rhizobium, and Agrobacterium. Due to the desirable biocompatibility, high water holding capacity, mechanical properties and permeability, and low toxicity, the BC is widely used in artificial skin, wound dressings, cartilage tissue engineering materials, and neurovascular, vascular and dental implant materials. However, due to the lack of biological activity, the efficacy of BC has to be improved in promoting wound healing. Natural polymer bioactive materials such as collagen, gelatin, hyaluronic acid and sericin are rich in sources and have excellent biocompatibility and biological activity. These materials have received more and more attention in the fields of biomedicine and tissue engineering, and have gradually become a research hotspot in the field of natural biomaterials. However, due to the poor mechanical properties when used alone, these materials need to be complexed with other materials to complement their strengths and weaknesses. In addition, remodeling of an extracellular matrix (ECM) plays a crucial role in the repair of skin tissue wounds. The ECM can serve as a dynamic scaffold for protection and promotion of wound repair, and as a signaling molecule for cell growth. Therefore, it is essential for improving the effectiveness and quality of skin repair by precise regulation of biochemical and biomechanical interactions for cell-matrix in space and time. In a previous study, a bacterial cellulose-silk sericin composite (BC-SS) was used as a wound dressing; results of in vitro studies showed that the composite could promote the proliferation of fibroblasts and epithelial cells, thereby promoting wound healing (Lamboni. L, Li.Y, Liu. J and Yang, G. BIOMACROMOT,E,CULES, 2016, 17, 3076-3084.). However, this skin repair dressing may cause uncontrolled proliferation of fibroblasts and lead to the deposition of excessive collagen, resulting in tissue fibrosis and scarring (Keane T. J., Horejs C., Stevens M. M., Adv. Drug Del/v. Rev., 2018, 129: 407-419; Coentro J. Q., Pugliese E., Hanley G., Raghunath M., Zeugolis D. I., Adv. Drug Del/v. Rev., 2019, 146: 37-59.).
SUNIMARY
[0004] The present disclosure solves the problem that the wound repair dressings can lead to uncontrolled proliferation of fibroblasts and lead to the deposition of excessive collagen in the prior art, resulting in tissue fibrosis and scarring. The present disclosure provides a preparation method of a patterned bacterial cellulose-based composite membrane with a biological activity as a wound dressing, where a bacterial cellulose-based membrane with a patterned structure is compounded with a natural polymer bioactive material. A composite membrane prepared by the preparation method has excellent mechanical properties and biological activity, and has a fine groove structure on a surface. The composite membrane can control the orientation arrange and growth morphology of cells, and promote rapid wound healing. The composite membrane can further induce uniform distribution of fibroblasts and deposited collagen, thereby reducing fibrosis and scarring.
[0005] A first aspect of the present disclosure is to provide a preparation method of a patterned bacterial cellulose-based membrane with a biological activity, including the following steps: [0006] (1) inverting a template with a patterned structure into a bacteria culture medium capable of synthesizing bacterial cellulose, and conducting culture to obtain a bacterial cellulose-based membrane with a patterned structure.
100071 (2) immersing the bacterial cellulose-based membrane with a patterned structure obtained in step (1) into a solution of a natural polymer bioactive material, such that the bacterial cellulose-based membrane with a patterned structure and the natural polymer bioactive material are compounded through a hydrogen bond force to obtain the patterned bacterial cellulose-based membrane with a biological activity.
[0008] Preferably, the patterned structure may be a striped groove structure.
[0009] Preferably, the striped groove structure may be formed by grooves of a uniform width, or first grooves and second grooves that have different widths and are alternately arranged; 100101 Preferably, the grooves of a uniform width each may have a width of 5 jun to 20 pm; and the first grooves each may have a width of 5 gm to 15 pm, and the second grooves each may have a width oft pm to 10 pm.
[0011] Preferably, the natural polymer bioactive material may be any one selected from the group consisting of seri ci n, collagen, gelatin, and hyaluroni c acid.
100121 Preferably, the bacteria capable of synthesizing bacterial cellulose may be any one selected from the gyoup consisting of Aceiobacter Mum, Azolobacter, ilgrobacterthm, Rhizobium, Pseudomoncts, and Alcahgenes.
100131 Preferably, in step (1), the culture may be conducted for 5 d to 7 d.
[0014] Preferably, a solute in the solution of the natural polymer bioactive material may have a mass fraction of 1% to 3%; and the immersion may be conducted for 12 h to 48 h. [0015] Preferably, the template with a patterned structure may be a polydimethylsiloxane (PDMS) template with a patterned structure.
[0016] Preferably, a preparation method of the PDMS template with a patterned structure may include the following steps: [0017] Sl: designing a pattern of a lithography mask, and subjecting the designed pattern to lithography on a silicon wafer to obtain a patterned photoresist template; and [0018] S2: fully mixing PDMS and a curing agent, removing air bubbles to obtain a transparent viscous liquid, and pouring the transparent viscous liquid onto the patterned photoresist template obtained in step Si; conducting heat curing, and peeling off the PDMS from the patterned photoresist template, to form the PDMS template with a patterned structure complementary to a structure of the patterned photoresist template.
[0019] A second aspect of the present disclosure is to provide a patterned bacterial cellulose-based membrane with a biological activity prepared by the preparation method.
[0020] A third aspect of the present disclosure is to provide the use of the patterned bacterial cellulose-based membrane with a biological activity in the preparation of a wound dressing; where [0021] preferably, the wound dressing may be used to control the orientation an-ange and growth morphology of cells, and to induce uniform distribution of fibroblasts and deposited collagen, thereby reducing the fibrosis and scarring.
100221 Overall, compared with the prior art, the above technical solutions of the present disclosure mainly have the following technical advantages: [0023] (1) The patterned bacterial cellulose-based membrane has a three-dimensional fiberous network structure, thus providing a spatial structure basis for uniformly compounding the natural polymer bioactive material. The patterned bacterial cellulose-based composite membrane has excellent mechanical properties, and desirable biological activity and biocompatibility.
100241 (2) The patterned bacterial cellulose-based composite membrane has a striped groove structure with an adjustable stripe width, which can guide cells to grow along the fiberous grooves, thereby controlling the orientation arrange and growth morphology of cells.
[0025] (3) The patterned bacterial cellulose-based composite membrane has a fine Groove structure on a surface, which can quickly induce tissue regeneration and promote rapid wound healing, and can induce uniform distribution of fibroblasts and deposited collagen, thereby reducing fibrosis and scarring 100261 (4) Preferably, the striped groove structure is formed by the grooves of a uniform width or alternately arranging the first groove and the second groove with different widths, which helps to adjust the growth and orientation of cells, and to rearrange the microfilaments, microtubules and cytoskeletons. The structure further affects the growth and changes in physiological behavior of cells, which promotes a rapid wound healing, and reduces fibrosis and scarring.
[0027] (5) The preparation method is simple and environmental-friendly, and can be conducted on a large scale.
BRIEF DESCRIPTION OF THE DRAWINGS
[0028] FIG. 1 shows a field emission scanning electron microscope (FESEM) image of an rBC membrane prepared in Comparative Example 1; 100291 FIG. 2 shows an FESEM image of an rBC-SS1 membrane prepared in Comparative Example 2; [0030] FIG. 3 shows an FESEM image of an rBC-SS2 membrane prepared in Comparative Example 2; 100311 FIG. 4 shows an optical microscope image of a PDNIS template with uniform groove width (10 um) prepared in Example 1; [0032] FIG. 5 shows an FESEM image of an mBC membrane prepared in Example 2; [0033] FIG. 6 shows an FESEM image of an mBC-SS1 membrane prepared in Example 4; 100341 FIG. 7 shows an FESEM image of an mBC-SS2 membrane prepared in Example 5; [0035] FIG. 8 shows test results of a relative cell proliferation rate of samples prepared in Comparative Examples 1-3 and Examples 5-7; 100361 FIG. 9 shows a laser confoca1 microscope image of NIFI-3T3 cells in the samples prepared in Comparative Examples 1-3 and Examples 5-7; [0037] FIG. 10 shows a digital photo of the samples prepared in Comparative Examples 1-3 and Example 5-7 in repairing rat skin damages; 100381 FIG. 11 shows quantitative test results of a wound healing rate of the samples prepared in Comparative Examples 1-3 and Example 5-7 in repairing the rat skin damages 100391 FIG. 12 shows H&E staining results of the samples prepared in Comparative Examples 1-3 and Example 5-7 in repairing the rat skin damages for 3 d; where a refers to a blank control, b refers to the rBC, c refers to the mBC, d refers to the rBC-SS2, e refers to the mBC-SS2, and f refers to the mBC-SS; 100401 FIG. 13 shows test results of a thickness of granulation tissues formed after the samples prepared in Comparative Examples 1-3 and Example 5-7 in repairing the rat skin damages for different days; 100411 FIG. 14 shows test results of a thickness of epidermis formed after the samples prepared in Comparative Examples 1-3 and Example 5-7 in repairing the rat skin damages for different days; [0042] FIG. 15 shows collagen-III immunohistochemical fluorescence staining images of the samples prepared in Comparative Examples 1-3 and Example 5-7 in repairing the rat skin damages for 7 d and 14 d; and [0043] FIG. 16 shows quantitative determination results of collagen-III synthesis of the samples prepared in Comparative Examples 1-3 and Example 5-7 in repairing the rat skin damages for 7 d and 14 d.
DETAILED DESCRIPTION OF THE EMBODIMENTS
100441 In order to make the aim, technical solutions, and advantages of the present disclosure more clear, the present disclosure is further described in detail below with reference to the figures and examples. It should be appreciated that the specific example described herein is only intended to explain the present disclosure and is not intended to limit the present disclosure. Further, the technical features involved in the various embodiments of the present disclosure described below may be combined with each other as long as they do not constitute a conflict with each other.
[0045] Comparative Example 1 100461 A preparation method of a BC membrane included: a Hestrin & Schramm medium was prepared, where each component and proportion were: citric acid (0.15%, w/v), disodium phosphate (0.27%, w/v), a yeast extract (0.5%, w/v), peptone (0.5%, w/v), and glucose (2%, w/v). Each of the component was dissolved in deionized water, sterilized at high temperature, and AceThhacter xylinum was inoculated in a sterilized medium, followed by conducting incubation in an incubator at 30 °C for 7 d. The boiling was conducted with a 1N4 NaOH solution to remove bacteria remained in the BC membrane, and the BC membrane was washed with the deionized water several times until a pH value was 7. FIG. 1 shows an FESEM image of a rBC (random ) BC) membrane. As can be seen from the figure, the nanoflbers are randomly arranged to form a network structure that communicates with each other.
[0047] Comparative Example 2 [0048] A preparation method of a BC/SS (silk sericin) composite membrane included: silkworm cocoons were cut into pieces, boiled at 120°C. for 1 h, and a solution was concentrated by dialysis, and freeze-dried to obtain an SS powder. SS solutions with mass fractions of 1%, 2% and 3% were prepared with deionized water, added to a BC membrane, immersed at room temperature for 24 h to obtain a BC/SS composite membrane, followed by washing with PBS to remove excessive SS. FIG. 2 and FIG. 3 are FESEM images of rBC-SS1 and rBC-552 membranes, respectively. It can be seen that the SS is uniformly distributed on a surface of the rBC membrane.
[0049] Example 1
[0050] Patterned design and a preparation method of a PDMS template included the following steps: [0051] (1) Uniform striped groove patterns with a width of 10 pm, or alternately-arranged striped groove patterns with a width of 10 m and 5 pm were designed using AutoCAD drawing software. The designed patterns were subjected to lithography on a silicon wafer, and a patterned surface was silanized by perfluorosilane to enhance the inertness of the patterned template surface to prolong a service life.
[0052] (2) two liquids, PDMS and a curing agent, were fully mixed according to a mass ratio of 10:1, and air bubbles were removed to obtain a transparent viscous liquid; bubble-removed PDMS was poured onto a patterned photoresist template with a thickness of 3 mm, and the air bubbles were further removed by vacuum.
[0053] (3) The template was placed in an oven to fully cure the PDMS, and the PDMS was carefully peeled off from the patterned photoresist template; the PDMS formed a pattern complementary to the template in concavity and convexity, and the pattern was cut into a required size for further use.
[0054] FIG. 4 shows an optical microscope image of the PDMS template grooves with a uniform width (10 pm). It can be seen from the figure that, the stripe structure of the groove is arranged in parallel, with a same width of each stripe.
[0055] Example 2
[0056] A preparation method of a patterned BC membrane included: a Hestrin & Schramm medium was prepared, where each component and proportion were: citric acid (0.15s4, w/v), disodium phosphate (0.27%, w/v), a yeast extract (0.5%, w/v), peptone (0.5%, w/v), and glucose (2%, w/v). Each of the component was dissolved in deionized water, sterilized at high temperature, and Acetobacter xylitutm was inoculated in a sterilized medium, a PDMS template with a stripe width of 10 um was inverted in the medium, followed by conducting incubation in a 30°C incubator for 7 d. Boiling was conducted with a 1M NaOH solution to remove bacteria remaining in the BC membrane, and the BC membrane was washed with the deionized water several times until a pH value was 7. FIG. 5 shows a FESEM image of the mBC membrane. It can be seen from the figure that the mBC is a neatly-arranged fiberous groove stnicture with a relatively dense directional arrangement.
100571 Example 3
[0058] A Hestrin & Schramm medium was prepared, where each component and proportion were: citric acid (0.15%, w/v), disodium phosphate (0.27%, w/v), a yeast extract (0.5%, w/v), peptone (0.5%, w/v), and glucose (2%, w/v). Each of the component was dissolved in deionized water, sterilized at high temperature, and Acetobacter xylinum was inoculated in a sterilized medium, alternately-arranged striped groove PDMS templates with a width of 10 um and 5 [trn were inverted in the medium, followed by conducting incubation in a 30°C incubator for 7 d. Boiling was conducted with a 1M NaOH solution to remove bacteria remaining in the BC membrane, and the BC membrane was washed with the deionized water several times until a pt-I value was 7, to obtain alternately-arranged fiberous groove structure membranes with different widths.
[0059] Example 4
100601 A preparation method of a patterned BC/SS composite membrane included the following steps: [0061] Silkworm cocoons were cut into pieces, boiled at 120°C for 1 h, and a solution was concentrated by dialysis, and freeze-dried to obtain an SS powder. An SS solution with a mass fraction of 1% was prepared with deionized water, added to a patterned BC membrane with a stripe width of 10 tun, immersed at room temperature for 24 h to obtain a patterned BC/SS composite membrane, followed by washing with PBS to remove excessive SS. FIG. 6 shows a FESEM image of an mBC-SS1 membrane It can be seen from the figure that the SS is uniformly compounded in the BC membrane.
[0062] Example 5
[0063] A preparation method of a patterned BC/SS composite membrane included the following steps: [0064] Silkworm cocoons were cut into pieces, boiled at 120°C for 1 h, and a solution was concentrated by dialysis, and freeze-dried to obtain an SS powder. An SS solution with a mass fraction of 2% was prepared with deionized water, added to a patterned BC membrane with a stripe width of 10 i.tm, immersed at room temperature for 24 h to obtain a patterned BC/SS composite membrane, followed by washing with PBS to remove excessive SS. FIG. 7 shows an FESENI image of an mBC-SS2 membrane.
[0065] Example 6
[0066] A preparation method of a patterned BC/SS composite membrane included: silkworm cocoons were cut into pieces, boiled at 120°C for 1 h, and a solution was concentrated by dialysis, and freeze-dried to obtain an SS powder. An SS solution with a mass fraction of 3% was prepared with deionized water, added to a patterned BC membrane with a stripe width of 10 pm, immersed at room temperature for 24 h to obtain an mBC-SS composite membrane, followed by washing with PBS to remove excessive SS.
[0067] Example 7
[0068] 0.2 g of collagen was dissolved in 10 mL of deionized water by stirring. After being completely dissolved, a collagen solution was added to an mBC membrane with a groove width of 10)tm, immersed at room temperature for 24 h to obtain a patterned BC-collagen composite membrane, followed by washing with PBS to remove excessive collagen to obtain a collagen-modified mBC functional membrane.
[0069] Example 8
[0070] 0.2 g of gelatin was dissolved in 10 mL of deionized water by stirring. After being completely dissolved, a gelatin solution was added to an mBC membrane with a groove width of 10 gm, immersed at room temperature for 24 h to obtain a patterned BC-gelatin composite membrane, followed by washing with PBS to remove excessive gelatin to obtain a gelatin-modified mBC functional membrane.
[0071] Example 9
[0072] 0.2 g of hyaluronic acid was dissolved in 10 mL of deionized water by stirring. After being completely dissolved, a hyaluronic acid solution was added to a patterned BC membrane with a first groove in 5 pm width and a second groove in 10 pm width that were alternately-arranged, immersed at room temperature for 24 h to obtain an mBC-hyaluronic acid composite membrane, followed by washing with PBS to remove excessive hyaluronic acid to obtain a hyaluronic acid-modified mBC functional membrane.
[0073] Example 10
[0074] The cytocompatibility of composite membranes mBC, mBC-SS1, mBC-SS2, and mBCSS3 prepared in Examples 1, 2, 3, and 4, as well as composite membranes rBC, rBC-SS1, rBCSS2, and rBC-SS3 prepared in Comparative Examples 1 and 2 were evaluated using NIH-3T3 (mouse embryonic fibroblast cell line) as a model cell. The two types of cells were cultured in a CO, incubator at 37°C and 5% CO2; when the cell fusion reached to 80% to 90%, the cells were seeded on each group of the materials, with an amount of the cells (6x 1040 seeded on each material, after 1 d, 3 d, and 5 d of culture, a cell viability assay was conducted with CCK-8, where each sample was repeated three times; and a relative cell proliferation rate was calculated. FIG. 8 and FIG. 9 show test results of a relative cell proliferation rate and a laser confocal microscope image of NIH-3T3 cells grown on the materials in the samples prepared in Comparative Examples 1-3 and Examples 5-7. It can be seen from the figures that the mBC composite membrane can promote cell proliferation more than the rBC composite membrane, and can guide cells to grow along the fiberous grooves, indicating that the mBC composite membrane has a desirable potential for use in inducing tissue oriented growth.
100751 Example 11
[0076] Approved by the Laboratory Animal Experiment Ethics Committee of Wuhan Servicebio Technology Co., Ltd., adult male Wistar rats were used for in vivo experiments. 16 adult male Wistar rats weighing 300 g to 500 g were randomly divided into four groups: 3 d, 7 d, 14 d, and 21 d according to an experimental time point. The rats were anesthetized, and traumatic surgery was conducted following standard aseptic procedures. The back of rat was shaved to create 6 circular wounds of 9 mm in diameter. All 6 wounds were treated with different dressings including mBC, mBC-SS1, mBC-SS2, rBC, rBC-SS2 and gauze (as a control). A microstructured surface of the mBC and its composite were in contact with the wound, while a smooth surface of the rBC and its composite were in contact with the wound. According to preliminary test results of 7 d, the dressing was changed every 48 h for the first 7 d, and every 24 h for the rest of the time. According to the surface structure of the BC and its composites, the dressing was kept in the wound for 48 h to induce the distribution of cells, especially fibroblasts. FIG. 10 shows a digital photo of the samples of each group in repairing rat skin damages; FIG. 11 shows corresponding quantitative test results of a wound healing rate. It can be seen from the figures that the mBC and rBC composite membrane groups have higher wound healing speed and wound healing rate than that of the control group, showing great advantages in skin damage repair. FIG. 12 shows H&E staining results of the samples of each group in repairing the rat skin damages for 3 d; where a refers to a blank control, b refers to the rBC, c refers to the mBC, d refers to the rBC-SS2, e refers to the mBC-SS2, and f refers to the mBC-SS1. It can be seen that obvious granulation tissues were seen in the rBC and mBC groups, while no granulation tissue was formed in the blank control group. Furthermore, the rBC-SS2, mBC-SS1 and mBC-SS2 composite groups present more significant granulation tissue formation relative to the rBC group. From the results of quantitative analysis on granulation tissue formation (FIG. 13), it is found that the thickness of granulation tissue formation increases in different groups on 7th day; on 14th and 21th days, the thickness of granulation tissue formation decreases. The reason is that in each group, the transition of skin tissue from hyperplasia to remodeling is more obvious in mBC and mBC-SS2 groups than that in rBC and rBC-SS2 groups. This indicates that the mBC-SS2 composite can effectively inhibit the overgrowth of new tissues. FIG. 14 shows results of a quantitative test of epidermal layer thickness in skin repair. On the 7th day, except for the total lesion skin group (control) without epithelization, the rest groups have obvious epithelization. On days 14 and 21, the thickness of nascent epidermis on the different BC groups is reduced relative to that on day 7, possibly due to the transformation of proliferated keratinocytes into keratinized cells during the epidermal remodeling. In addition, FIG. 15 and FIG. 16 show the immunohistochemical fluorescence staining and quantitative test results of collagen-III production in different groups, respectively. From the experimental results, it is found that on day 7, except for the blank control group and the single BC group, the other groups significantly promote the secretion of collagen-III, indicating that the compounding of sericin improves the synthesis of collagen. On the 14th day, the secretion of collagen-III in the mBC and mBC-SS2 groups is lower than that in the other groups, and the synthesis amount of collagen-III in the mBC-SS group is significantly lower than that in the other groups. This indicates that there is no excessive wound contraction in the mBC-SS group relative to the other groups, indirectly reflecting the prevention of fibrosis and scarring in this group.
100771 It is easy for those skilled in the art to understand that the above-mentioned contents are merely the preferred examples of the present disclosure, and are not intended to limit the present disclosure. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present disclosure should fall within the protection scope of the present disclosure.
Claims (10)
- WHAT IS CLAIMED IS: 1. A preparation method of a patterned bacterial cellulose-based membrane with a biological activity, comprising the following steps: (1) inverting a template with a patterned structure into a bacteria culture medium capable of synthesizing bacterial cellulose, and conducting culture to obtain a bacterial cellulose-based membrane with a patterned structure; and (2) immersing the bacterial cellulose-based membrane with a patterned structure obtained in step (1) into a solution of a natural polymer bioactive material, such that the bacterial cellulose-based membrane with a patterned structure and the natural polymer bioactive material are compounded through a hydrogen bond force to obtain the patterned bacterial cellulose-based membrane with a biological activity.
- 2. The preparation method of a patterned bacterial cellulose-based membrane with a biological activity according to claim 1, wherein the patterned structure is a striped groove structure.
- 3. The preparation method of a patterned bacterial cellulose-based membrane with a biological activity according to claim 2, wherein the striped groove structure is formed by grooves of a uniform width, or first grooves and second grooves that have different widths and are alternately arranged; preferably, the grooves of a uniform width each have a width of 5 um to 20 gm; and the first grooves each have a width of 5 pm to 15 gm, and the second groove each have a width of 1 um to 10 um
- 4. The preparation method of a patterned bacterial cellulose-based membrane with a biological activity according to claim 1, wherein the natural polymer bioactive material is any one selected from the group consisting of sericin, collagen, gelatin, and hyaluronic acid; and preferably, the bacteria capable of synthesizing bacterial cellulose are any one selected from the group consisting of Acetohacter xylinum, Azotohacter, Agrohacterium, Rhizohium, I' sendomonas, and Alcahgenes.
- 5. The preparation method of a patterned bacterial cellulose-based membrane with a biological activity according to claim 1, wherein in step (1), the culture is conducted for 5 d to 7 d.
- 6. The preparation method of a patterned bacterial cellulose-based membrane with a biological activity according to claim I, wherein a solute in the solution of the natural polymer bioactive material has a mass fraction of 1% to 3%, and the immersion is conducted for 12 h to 48 h.
- 7. The preparation method of a patterned bacterial cellulose-based membrane with a biological activity according to claim 1, wherein the template with a patterned structure is a polydimethylsiloxane (PDMS) template with a patterned structure
- 8. The preparation method of a patterned bacterial cellulose-based membrane with a biological activity according to claim 7, wherein a preparation method of the PDMS template with a patterned structure comprises the following steps: Si: designing a pattern of a lithography mask, and subjecting the designed pattern to lithography on a silicon wafer to obtain a patterned photoresist template; and S2: fully mixing PDMS and a curing agent, removing air bubbles to obtain a transparent viscous liquid, and pouring the transparent viscous liquid onto the patterned photoresist template obtained in step Si; conducting heat curing, and peeling off the PDMS from the patterned photoresist template, to form the PDMS template with a patterned structure complementary to a structure of the patterned photoresist template.
- 9. A patterned bacterial cellulose-based membrane with a biological activity prepared by the preparation method according to any one of claims 1 to 8.
- 10. Use of the patterned bacterial cellulose-based membrane with a biological activity according to claim 9 in the preparation of a wound dressing; wherein preferably, the wound dressing is used to control the orientation arrange and growth morphology of cells, and to induce uniform distribution of fibroblasts and deposited collagen, thereby reducing fibrosis and scarring.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110347756.3A CN113069275A (en) | 2021-03-31 | 2021-03-31 | Patterned bacterial cellulose composite membrane with bioactivity, preparation and application |
Publications (2)
Publication Number | Publication Date |
---|---|
GB202204571D0 GB202204571D0 (en) | 2022-05-11 |
GB2609691A true GB2609691A (en) | 2023-02-15 |
Family
ID=76614806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2204571.0A Pending GB2609691A (en) | 2021-03-31 | 2022-03-30 | Patterned bacterial cellulose (BC) composite membrane with biological activity, and preparation method and use thereof |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN113069275A (en) |
GB (1) | GB2609691A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115089772A (en) * | 2022-05-24 | 2022-09-23 | 华南理工大学 | Use of surfaces with micro-topology for anti-fibrosis of implanted medical devices |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108939131A (en) * | 2018-07-27 | 2018-12-07 | 武汉纺织大学 | A kind of preparation method of two-layer compound bletilla striata base dressing |
CN109381742A (en) * | 2017-08-09 | 2019-02-26 | 国家纳米科学中心 | Three-dimensional artificial interverbebral disc and its preparation method and application based on patterning bacteria cellulose |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101285083B (en) * | 2008-05-30 | 2011-06-29 | 华中科技大学 | Process for preparing patterned cellulosic by micro-fluidic chip |
CN102219917B (en) * | 2011-04-13 | 2012-10-10 | 华中科技大学 | Flexible display material based on bacterial cellulose |
CN110893248A (en) * | 2018-09-12 | 2020-03-20 | 深圳市诺亚特科技有限公司 | Surface microprotrusion patterned material and application thereof in body surface wound healing and scar repair |
CN109384952B (en) * | 2018-09-14 | 2020-06-09 | 华中科技大学 | Patterned bacterial cellulose membrane and preparation method and application thereof |
CN109608684B (en) * | 2018-10-29 | 2020-10-02 | 华中科技大学 | Three-dimensional shaped bacterial cellulose and preparation method and application thereof |
-
2021
- 2021-03-31 CN CN202110347756.3A patent/CN113069275A/en active Pending
-
2022
- 2022-03-30 GB GB2204571.0A patent/GB2609691A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109381742A (en) * | 2017-08-09 | 2019-02-26 | 国家纳米科学中心 | Three-dimensional artificial interverbebral disc and its preparation method and application based on patterning bacteria cellulose |
CN108939131A (en) * | 2018-07-27 | 2018-12-07 | 武汉纺织大学 | A kind of preparation method of two-layer compound bletilla striata base dressing |
Also Published As
Publication number | Publication date |
---|---|
GB202204571D0 (en) | 2022-05-11 |
CN113069275A (en) | 2021-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6140240B2 (en) | Silk organs made by tissue engineering | |
Saburi et al. | In vitro osteogenic differentiation potential of the human induced pluripotent stem cells augments when grown on Graphene oxide-modified nanofibers | |
RU2602620C2 (en) | Silica sol and cellular complex, tissue and/or body with a fibrous matrix of the polysilicic acid | |
AU2016364627A1 (en) | Light-activated preparation of hydrogels | |
Biazar et al. | The healing effect of stem cells loaded in nanofibrous scaffolds on full thickness skin defects | |
Li et al. | From 2D to 3D: The morphology, proliferation and differentiation of MC3T3-E1 on silk fibroin/chitosan matrices | |
Xu et al. | Bioprinting a skin patch with dual-crosslinked gelatin (GelMA) and silk fibroin (SilMA): An approach to accelerating cutaneous wound healing | |
Psycharakis et al. | Tailor-made three-dimensional hybrid scaffolds for cell cultures | |
Fu et al. | P34HB electrospun fibres promote bone regeneration in vivo | |
US11299630B2 (en) | Templated assembly of collagen fibers and uses thereof | |
RU2483756C1 (en) | METHOD FOR PREPARING BIODEGRADED COMPOSITE MATRIX OF REGENERATED SILK FIBROIN Bombyx mori AND ITS USE | |
Makita et al. | Preparation of micro/nanopatterned gelatins crosslinked with genipin for biocompatible dental implants | |
CN112870439A (en) | Nano fiber bone tissue engineering scaffold with core-shell-series crystal structure and preparation method thereof | |
GB2609691A (en) | Patterned bacterial cellulose (BC) composite membrane with biological activity, and preparation method and use thereof | |
Wang et al. | A study on in vitro and in vivo bioactivity of silk fibroin/nano-hydroxyapatite/graphene oxide composite scaffolds with directional channels | |
CN112426569B (en) | Inorganic-organic composite living cell scaffold and preparation method and application thereof | |
Morelli et al. | Recent strategies combining biomaterials and stem cells for bone, liver and skin regeneration | |
Wu et al. | Bacterial cellulose nanofiber distribution on gelatin and silk fibroin scaffolds and the cell behavior | |
Wang et al. | Preparation and biological properties of silk fibroin/nano-hydroxyapatite/hyaluronic acid composite scaffold | |
JP3616344B2 (en) | Chondrocyte culture method and cartilage tissue regeneration substrate | |
Oh et al. | Fabrication and characterization of epithelial scaffolds for hair follicle regeneration | |
Kim et al. | Fabrication of nanofibrous silkworm gland three-dimensional scaffold containing micro/nanoscale pores and study of its effects on adipose tissue-derived stem cell growth | |
Tan et al. | Research on the osteogenesis and biosafety of ECM–Loaded 3D–Printed Gel/SA/58sBG scaffolds | |
Halib et al. | Micropatterned κ-carrageenan-PVP-PEG hydrogels as a templet for head and neck cancer spheroid culture | |
Volkova et al. | Three-dimensional matrixes of natural and synthetic origin for cell biotechnology |